Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study
Introduction: Immune checkpoint inhibitors (ICIs) exert antitumor responses in many types of cancer but may also induce serious or fatal toxicities that affect all organ systems, including the hematologic and lymphatic systems. However, the risk of hematologic and lymphatic system toxicities followi...
Saved in:
Main Authors: | Na Li (Author), Yong Feng (Author), XiaoLing Chen (Author), Ye Li (Author), Chengmiao Zhang (Author), Yin Yin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
by: Katarina Hradska, et al.
Published: (2021) -
Immune Checkpoint Inhibitor-Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
by: Li Wang, et al.
Published: (2021) -
Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia
by: Roser Calvo
Published: (2019) -
Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis
by: Yana Yang, et al.
Published: (2024) -
Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
by: Xiaoling Gong, et al.
Published: (2022)